Active Ingredient: BUDESONIDE
Proprietary Name: BUDESONIDE
Dosage Form; Route of Administration: AEROSOL, FOAM; RECTAL
Strength: 2MG/ACTUATION
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A215328
Product Number: 001
Approval Date: Apr 12, 2023
Applicant Holder Full Name: PADAGIS ISRAEL PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
